In 1990 and 1996, field veterinarians suspected the clinical occurrence of bovine ephemeral fever among dairy and conventional cattle in different regions of Saudi Arabia. The disease has a seasonal occurrence; it begins in early summer (May) and ends in late autumn (November).The mortality rate is low: 0.3% to 0.6%. The morbidity rate ranged from 5% to 61% within the different age groups of one affected herd in the 1996 outbreaks and from 3.4% to 19% among four affected herds in the 1990 outbreaks. A sudden sharp drop in milk production occurred in lactating animals, some of which had become dry by the end of the outbreaks. Trials to isolate the causative virus in cell culture and in baby mice were unsuccessful. Serum neutralisation tests, which used a cell culture-adapted vaccine strain of bovine ephemeral fever virus as an antigen, revealed the presence of specific antibodies with significantly increased titres in the convalescent sera of affected animals. In addition, the testing of paired sera from non-affected heifers and from both dry and milking cows, performed twice, with an interval of 21 days, revealed the presence of neutralising antibodies. In the 1990 outbreaks, comparative serological studies indicated a high percentage (67.5%; 27/40) of seropositive animals in herds in which bovine ephemeral fever had been previously suspected. No antibodies were detected in animals of herds which had no recorded clinical history of bovine ephemeral fever. Following serological confirmation of the prevalence of bovine ephemeral fever in Saudi Arabia, some dairy farms started using a live imported vaccine to control the disease. This study discusses the epizootiological findings in regard to bovine ephemeral fever, as well as its economic impact on four affected dairy farms in 1990. In addition, the authors evaluate the efficacy of immunoprophylaxis in another dairy herd during the same outbreaks.
Introduction
Although it has been assumed that bovine ephemeral fever is prevalent in the Arabian peninsula (16, 17) , there have been no published laboratory data to confirm this assumption. In The objective of this study is to analyse the results of the virological, serological and epizootiological investigations conducted during those epizootics which were serologically diagnosed as being bovine ephemeral fever. In addition, some preliminary data on the economic impact of the disease, as well as on the efficacy of using a live modified imponed vaccine to control bovine ephemeral fever, are also discussed.
Materials and methods
To investigate the course of the disease, seroconversion and the economic impact on dairy farms, several affected and non-affected farms were chosen to be the subject of the study (one affected farm in the Eastern region of Saudi Arabia during the 1996 outbreaks in addition to four affected and two non-affected farms located in the Central and Eastern regions during the 1990 outbreaks).
Epizootiological data
Data on the observed clinical signs, dates and geographic locations of the relevant disease syndromes were provided by field veterinarians.
Samples for laboratory diagnosis Virus isolation
During the 1990 and 1996 outbreaks, non-coagulated blood samples from clinical cases in which animals had a body temperature higher than 40°C were collected for virological diagnosis. Culicoides midges and mosquitoes were also provided by the staff of the affected farms to be used for virus isolation.
Seroconversion
Acute and convalescent paired serum samples and paired sera (10 of each) were collected from clinically affected and non-affected heifers at an interval of 21 days, as well as from milking and dry cows, respectively, within the same herd, affected during the 1996 outbreaks.
For comparative serological studies, 40 and 20 sera (10 sera from each herd) were collected from the four affected and two unaffected dairy herds chosen for study during the 1990 outbreaks.
Vaccinated herd from an infected area during the 1S96 outbreaks
A total of 48 sera were collected from three-year-old milking cows on a dairy farm located in an infected area in the Central region. Annual routine vaccination with a live bovine ephemeral fever vaccine, containing attenuated virus combined with the Quil A adjuvant, had been conducted on this farm since 1990.
Vaccination of dairy cattle with live bovine ephemeral fever vaccine
Vaccination field trials used a commercial modified live bovine ephemeral fever vaccine containing attenuated virus combined with the Quil A adjuvant. The dose was 2 ml, administered subcutaneously on the side of the neck. Pre-and post-vaccination serum samples were taken from 36 animals of different age groups in a herd which had been vaccinated with two doses at an interval of 30 days.
Virus neutralisation tests
Micro-neutralisation tests, which have been previously described (3), were conducted, using Vero cell line and a cell culture-adapted vaccine strain of bovine ephemeral fever virus as antigen. 
Results

Chronological occurrence and geographical distribution
Clinical symptoms
The collected data indicated that the first sign in affected animals was usually slight pyrexia (40°C to 41.5°C), which Milk production dropped significantly and the quality of the remaining milk usually deteriorated. Thus, it was necessary to cull some of the milking cows for economic reasons. Three days after the onset of fever, the majority of the affected animals gradually recovered. A few cases of abortion and mortality were reported during some outbreaks.
Courses of some outbreaks of bovine ephemeral fever on dairy farms in 1990 and 1996
On the dairy farm affected during the 1996 outbreaks, the reported data revealed that all age groups of dairy cattle were affected, except calves younger than two months, with morbidity rates ranging from 5% to 61% (Table I ). The longest outbreak was 51 days (Fig. 2) . Milk yields before and during the outbreak were studied every 15 days. A sudden sharp drop in milk yield was observed during the outbreak.
Of 82 affected cows, 77 had become dry by the end of the outbreak (Table II) .
During the 1990 outbreaks, four affected dairy farms were studied. The morbidity rates were: 17.3% (294/1,700), 19.3% 
Losses due to bovine ephemeral fever
Economic losses caused by bovine ephemeral fever on these dairy farms included the following:
-a sudden sharp drop in milk production -the low sales price of the dead animals I   1  3  5  7  9  11  13  15  17  19 21  23  25  27  29  31  33  35  37  39 41  43  45  47  49  51 Duration of outbreak (days) 
Virus isolation trials
Trials to isolate the causative virus from the buffy coats of febrile animals and suspension of the pooled Culicoides and mosquito samples in Vero cells and baby mice were unsuccessful. 
Virus neutralisation tests Affected and non-affected herds in the 1990 outbreaks
Neutralising antibody against the virus of the imported bovine ephemeral fever vaccine strain was detected in 67.5% (27/40) of convalescent sera collected from animals recovering from bovine ephemeral fever in the four herds studied, with titres ranging from 4 to 256 (Fig. 4) . A total of 20 sera were collected from the two non-affected dairy herds located in central Saudi Arabia. Test results revealed that these animals had no detectable neutralising antibodies (Fig. 4) .
Acute, convalescent and non-affected animals within the same herd, in the 1996 outbreaks
The results indicated the presence of high neutralising antibody titres ranging from 16 to 256 in the convalescent sera collected from clinically affected heifers and milking and dry cows (Fig. 5 ) in this herd. Moreover, the Examination of 48 sera collected from three-year-old milking cows on a dairy farm which has employed routine vaccination against bovine ephemeral fever since 1990, and is located in an infected area in central Saudi Arabia, showed that the vaccinated animals displayed neutralisation titres which ranged from 128 to 1,024, three months after the annual booster dose (Fig. 6 ).
* The reciprocal of the highest serum dilution which neutralises 100 TCID50 of virus 
Vaccinating animals with live bovine ephemeral fever virus vaccine after the 1990 outbreaks
In field trials, a total of 36 animals of different age groups, from a commercial dairy herd which had no clinical history of bovine ephemeral fever, were tested. Each animal was given two injections of live vaccine, 30 days apart. Neutralising antibody titres measured at the time of the primary and booster vaccinations are shown in Figure 7 . The antibody response 30 days after primovaccination was relatively moderate, with average titres ranging from 80 to 213.
A sharp peak in antibody response was detected two months after the booster dose in all groups of animals, with average titres ranging from 448 to 853.
Discussion
The seasonal occurrence of, and clinical and epizootiological findings in relation to the disease observed in this study coincide with those features of bovine ephemeral fever or 'three-days' sickness' reported in Australia, Japan, South Africa, China and India (7, 8, 10, 11, 14, 15, 18, 20, 31, 32) . Three factors seem particularly to have influenced the pattern of the spread of disease in these outbreaks, as follows:
-unusually heavy and prolonged rainfall in 1990 and 1996 Therefore, these outbreaks were attributed to the introduction of viraemic animals through the importation of live animals. In addition, the disease could have spread to other regions either by being wind-borne (13, 19) or through the uncontrolled movement of viraemic feedlot and conventional cattle. On the other hand, the presence of wild ruminants which act as a reservoir for bovine ephemeral fever (4, 5, 6) and the apparent disappearance of bovine ephemeral fever neutralising antibodies acquired during the 1990 outbreaks, as well as increased activity of Culicoides and mosquitoes, could have influenced the pattern of disease spread during the 1996 outbreaks.
It was impossible to isolate the causative virus either from viraemic animals or from the Culicoides and mosquitoes which were collected during the 1990 and 1996 outbreaks. The failure to isolate bovine ephemeral fever virus from non-coagulated blood may be due to the samples from the buffy coats not being sufficiently fresh or to the presence of early antibodies in the blood of the affected animals (21).
In the 1990 outbreaks, high levels (4 to 256) of neutralising antibodies against bovine ephemeral fever virus were detected in 27 out of 40 sera, collected from animals which had recovered from a disease showing clinical signs similar to those of bovine ephemeral fever on the four affected dairy farms. Such antibodies were absent in the 20 sera collected from animals of two non-affected herds. These are significant indications that the suspected disease was bovine ephemeral fever. The absence of any history of vaccination against bovine ephemeral fever in Saudi Arabia before 1990 indicates that the detection of specific antibodies against bovine ephemeral fever virus is due to natural infection with the virus, which can be assumed to be prevalent in the environment of Saudi Arabia.
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